astma. Asthm
Conditions
Interventions
Intervention 1: Intervention group: 300 mg capsules of magnesium sulfate were given to patients in this group every 12 hours for 5 days. Intervention 2: Control group: Placebo capsules with the same
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
5 Years to 12 Years
Inclusion criteria
Inclusion criteria: Asthma attack diagnosis based on history and clinical examination of patients diagnosed asthma by asthma specialist.modrate and severe asthma attacks in asthmatic children aged 5 to 12 years. The consent of the child and his legal guardian to enter the study.
Exclusion criteria
Exclusion criteria: Exclusion criteria: Mild asthma attacks that could be treated on an outpatient basis and at home. The presence of other chronic underlying conditions other than asthma, such as heart disease, renal or pulmonary disease. The use of drugs that affects the magnesium absorption and secretion mechanism include diuretics, digoxin, calcium supplements. Failure to use the drug by the patient and lack of proper follow up by the parent. Severe complications of the drug
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| The speed of symptom improvement. Timepoint: When visiting, after 2 hours, 6 hours and 24 hours of referral, and then daily for up to 5 days. Method of measurement: questionnaire. | — |
Primary
| Measure | Time frame |
|---|---|
| Improve the symptoms of asthma. Timepoint: At the time of visit, 2,6,24 hours after the visit, and daily for up to 5 days. Method of measurement: quetionnary. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMelika Zarei Sani
Mashhad University of Medical Sciences
Outcome results
None listed